drugs glp 1 Comparing Ozempic, Wegovy and Other GLP-1 Half of GLP-1 users ditch

But until now, there hasnt been any data from large epidemiologic studies. Results showed use of GLP-1 agonists compared with bupropion-naltrexone correlated with a 9.09 (95% CI, 1.25-66), 4.22 (95% CI, 1.02-17.4) and 3.67 (95% CI, 1.15-11.9) times higher risk for pancreatitis, bowel obstruction and gastroparesis, respectively

However, the medication discontinuation rates were greater than 50% across all doses compared to 40% with placebo, with the most common adverse events (AE) being gastrointestinal in nature [27]

The American Society for Reproductive Medicine, Endocrine Society, the European Society of Human Reproduction and Embryology and the European Society for Endocrinology provided partnership funding

[DOI] [PMC free article] [PubMed] [Google Scholar] 5.Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D

What eye symptoms require urgent medical attention whilst taking GLP-1 medications